Long-term evolution of childhood epilepsy treated with vigabatrin, outside clinical trials;Seguimiento a largo plazo de la epilepsia infantil tratada con vigabatrina, fuera de los ensayos clinicos

Revista de Neurologia

Volumn 29, Issue 3, 1999, Pages 201-207

  Garaizar, C ^a   Martinez Gonzalez Ma J ^a   Fernandez Cuesta Ma A ^a   Prats, J Ma ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

Infantile spasms; Lennox Gastaut syndrome; Long term follow up; Refractory childhood epilepsy; Vigabatrin

Indexed keywords

VIGABATRIN;

ADOLESCENT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CEREBRAL PALSY; CHILD; DRUG EFFICACY; EPILEPTIC STATE; FEMALE; FOLLOW UP; GRAND MAL SEIZURE; HUMAN; INFANT; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOMES RESEARCH; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WEST SYNDROME;

EID: 0033172451     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.2903.99069     Document Type: Article

References (34)

1. Commission on Antiepileptic Drugs of The International League. Guidelines for clinical evaluation of antiepileptic drugs. Epilepsia 1989; 30: 400-8.
2. Brodie MJ. Antiepileptic drugs, clinical trials, and the marketplace. Lancet 1996; 347: 777-9.
3. Wong IC. Study suggests that under a quarter of patients will still be taking the new drugs after six years. Br Med J 1997; 314: 603-4.
4. Cramer JA. Quality of life for people with epilepsy. Neurol Clin 1994; 12: 1-14.
5. Elferink AJA, van Zwieten-Boot BJ. Analysis based on number needed to treat shows differences between drugs studied. Br Med J 1997; 314: 603.
6. Mignot G. Drug trials in epilepsy. Br Med J 1996; 313: 1158.
7. Aicardi J, Sabril IS, Investigator and Peer Review Groups, Mumford JP, Dumas C, Wood S. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Epilepsia 1996; 37: 638-42.
8. Casas C, Arcas J, Arteaga R, Castro-Gago M, Domingo M, Eirís J, et al. Espasmos infantiles. Tratamiento con vigabatrina. Análisis retrospectivo multicéntrico de resultados. Rev Neurol 1995; 23: 1258. (Resumen).
9. Commission on Classification and Terminology of The International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22: 489-501.
10. Commission on Classification and Terminology of The International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 66: 389-99.
11. Mattson RH, Cramer JA, Collins JF, the Department of Veterans Affairs Epilepsy Cooperative Study N.o 264 Group. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992; 327: 765-71.
12. Prats-Viñas JM, Garaizar C. Espasmos infantiles (síndrome de West): características y opciones terapéuticas. Rev Neurol 1996; 24: 1411-4.
13. Garaizar C, Sousa T, Lambarri I, Martín MA, Prats JM. Los datos clínicos de la demanda asistencial en la consulta neuropediátrica. Rev Neurol 1997; 25: 187-93.
14. Berg AT, Levy SR, Novotny EJ, Shinnar S. Predictors of intractable epilepsy in childhood: a case-control study. Epilepsia 1996; 37: 24-30.
15. Kälväinen R, Aikä M, Saukkonen AM, Mervaala E, Riekkinen PJ. Vigabatrin vs. carbamazepine monotherapy in patients with newly diagnosed epilepsy. Arch Neurol 1995; 52: 989-96.
16. Tanganelli P, Regesta G. Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study. Epilepsy Res 1996; 25: 257-62.
17. Livingston JH, Beaumont D, Arzimanoglou A, Aicardi J. Vigabatrin in the treatment of epilepsy in children. Br J Clin Pharmacol 1989; 27 (Suppl 1): 109S-12.
18. Mumford JP, Dam M. Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol 1989; 27 (Suppl 1): 101S-7.
19. Ferrie CD, Robinson RO. The clinical efficacy of vigabatrin in children. Rev Contemp Pharmacother 1995; 6: 469-76.
20. Pitkänen A, Ylinen A, Matilainen R, Luukkainen R, Mervaala E, Seppänene R, et al. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study. Arch Neurol 1993; 50: 24-9.
21. Sivenius J, Ylinen A, Murros K, Mumford JP, Riekkinen PJ. Vigabatrin in drug-resistant partial epilepsy: a 5-year follow-up study. Neurology 1991; 41: 562-5.
22. Uldall P, Alving J, Gram L, Gogenhaven H. Vigabatrin in childhood epilepsy: a 5-year follow-up study. Neuropediatrics 1995; 26: 253-6.
23. Walker MC, Sander JWAS. The impact of new antiepileptic drugs on the prognosis of epilepsy: seizure freedom should be the ultimate goal. Neurology 1996; 46: 912-4.
24. Arteaga R, Herranz JL, Armijo JA. Add-on vigabatrin in children with refractory epilepsy. A 4-year follow-up study. Clin Drug Invest 1996; 12: 287-97.
25. Lortie A, Chiron C, Mumford J, Dulac O. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology 1993; 43 (Suppl 5): S24-7.
26. Schapel G, Chadwick D. A survey comparing lamotrigine and vigabatrin in everyday clinical practice. Seizure 1996; 5: 267-70.
27. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313: 145-51.
28. Smith D, Baker O, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993; 34: 312-23.
29. Garaizar C, Pérez-García J, Gil-Antón J, Prats JM. Fracaso terapéutico, tratamiento y no tratamiento de la epilepsia infantil. Rev Neurol 1998; 27: 467-72.
30. Walker MC, Li LM, Sander JWAS. Long term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome. Br Med J 1996; 313: 1184-5.
31. Reynolds EH. Do anticonvulsants alter the natural course of epilepsy? Treatment should be started as early as possible. Br Med J 1995; 310: 176-7.
32. Chadwick D. Do anticonvulsants alter the natural course of epilepsy? Case for early treatment is not established. Br Med J 1995; 310: 177-8.
33. Sillanpää M. Remission of seizures and predictors of intractability in long-term follow-up. Epilepsia 1993; 34: 930-6.
34. Shinnar S, Berg AT. Does antiepileptic drug therapy prevent the development of 'chronic' epilepsy? Epilepsia 1996; 37: 701-8.